Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049452

Director sold 1,184 shares at $14.30 ($16,931)

  • Director acquired 2,366 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gallagher Carol Giltner Director 2017-08-15 Option exercise +1,548 108,922 D
Gallagher Carol Giltner Director 2017-08-15 Option exercise +818 109,740 D
Gallagher Carol Giltner Director 2017-08-16 Sale −1,184 $14.30 $16,931 108,556 D
Derivatives
Gallagher Carol Giltner Director 2017-08-15 Option exercise · Restricted Stock Units −1,548 3,097 D
Gallagher Carol Giltner Director 2017-08-15 Option exercise · Restricted Stock Units −818 2,179 D
Open-market sales · 1,184 sh · avg $14.30 · $16,931
Loading xslF345X03/doc4.xml…